John G. Ullman & Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,530
| Closed | -$211K | – | 184 |
|
|
2025
Q4 | $211K | Sell |
1,530
-1,450
| -49% | -$190K | 0.03% | 173 |
|
|
2025
Q3 | $382K | Sell |
2,980
-134,427
| -98% | -$16.4M | 0.05% | 139 |
|
|
2025
Q2 | $16.6M | Sell |
137,407
-716
| -0.5% | -$80.7K | 2.47% | 9 |
|
|
2025
Q1 | $15.4M | Sell |
138,123
-1,267
| -0.9% | -$135K | 2.37% | 7 |
|
|
2024
Q4 | $13.6M | Sell |
139,390
-2,076
| -1% | -$221K | 2% | 10 |
|
|
2024
Q3 | $16.3M | Sell |
141,466
-35,782
| -20% | -$4.06M | 2.34% | 9 |
|
|
2024
Q2 | $18.9M | Sell |
177,248
-1,939
| -1% | -$195K | 2.88% | 6 |
|
|
2024
Q1 | $17.3M | Sell |
179,187
-1,713
| -0.9% | -$176K | 2.66% | 8 |
|
|
2023
Q4 | $18.3M | Sell |
180,900
-1,790
| -1% | -$173K | 2.9% | 7 |
|
|
2023
Q3 | $18.6M | Sell |
182,690
-2,245
| -1% | -$228K | 3.04% | 8 |
|
|
2023
Q2 | $18.7M | Sell |
184,935
-3,110
| -2% | -$311K | 2.88% | 7 |
|
|
2023
Q1 | $17.3M | Sell |
188,045
-6,166
| -3% | -$539K | 2.69% | 7 |
|
|
2022
Q4 | $17.6M | Sell |
194,211
-3,683
| -2% | -$310K | 2.81% | 9 |
|
|
2022
Q3 | $15M | Buy |
197,894
+9,180
| +5% | +$761K | 2.63% | 9 |
|
|
2022
Q2 | $16M | Buy |
188,714
+2,295
| +1% | +$201K | 2.56% | 10 |
|
|
2022
Q1 | $16.4M | Buy |
186,419
+8,180
| +5% | +$708K | 2.27% | 10 |
|
|
2021
Q4 | $15.6M | Buy |
178,239
+3,285
| +2% | +$273K | 2.14% | 12 |
|
|
2021
Q3 | $14.3M | Sell |
174,954
-180
| -0.1% | -$16.2K | 1.95% | 16 |
|
|
2021
Q2 | $16M | Sell |
175,134
-2,330
| -1% | -$207K | 2.08% | 16 |
|
|
2021
Q1 | $15.2M | Buy |
177,464
+7,031
| +4% | +$631K | 2.04% | 17 |
|
|
2020
Q4 | $16.1M | Buy |
170,433
+18,948
| +13% | +$1.66M | 2.49% | 9 |
|
|
2020
Q3 | $13.2M | Sell |
151,485
-1,000
| -0.7% | -$86.6K | 2.73% | 9 |
|
|
2020
Q2 | $13.3M | Sell |
152,485
-350
| -0.2% | -$30.2K | 3.25% | 7 |
|
|
2020
Q1 | $12.6M | Sell |
152,835
-2,515
| -2% | -$224K | 3.34% | 7 |
|
|
2019
Q4 | $14.7M | Sell |
155,350
-2,775
| -2% | -$249K | 2.53% | 7 |
|
|
2019
Q3 | $13.7M | Sell |
158,125
-675
| -0.4% | -$60.6K | 2.5% | 8 |
|
|
2019
Q2 | $14.5M | Sell |
158,800
-19,063
| -11% | -$1.61M | 2.55% | 8 |
|
|
2019
Q1 | $15.3M | Sell |
177,863
-2,734
| -2% | -$219K | 2.77% | 7 |
|
|
2018
Q4 | $13.9M | Sell |
180,597
-762
| -0.4% | -$59.3K | 2.8% | 8 |
|
|
2018
Q3 | $14M | Sell |
181,359
-234
| -0.1% | -$17.3K | 2.55% | 8 |
|
|
2018
Q2 | $12.3M | Buy |
181,593
+2,985
| +2% | +$206K | 2.32% | 10 |
|
|
2018
Q1 | $12.9M | Buy |
178,608
+1,869
| +1% | +$142K | 2.5% | 10 |
|
|
2017
Q4 | $13.3M | Buy |
176,739
+288
| +0.2% | +$21.7K | 2.65% | 9 |
|
|
2017
Q3 | $13.6M | Buy |
176,451
+45,444
| +35% | +$3.43M | 2.65% | 9 |
|
|
2017
Q2 | $9.8M | Buy |
131,007
+4,313
| +3% | +$306K | 1.94% | 13 |
|
|
2017
Q1 | $8.43M | Buy |
126,694
+9,554
| +8% | +$637K | 1.74% | 15 |
|
|
2016
Q4 | $7.65M | Buy |
117,140
+57,229
| +96% | +$3.71M | 1.6% | 19 |
|
|
2016
Q3 | $4.24M | Buy |
59,911
+6,288
| +12% | +$458K | 0.87% | 41 |
|
|
2016
Q2 | $3.96M | Sell |
53,623
-613
| -1% | -$42.4K | 0.81% | 44 |
|
|
2016
Q1 | $3.52M | Sell |
54,236
-2,577
| -5% | -$175K | 0.83% | 39 |
|
|
2015
Q4 | $4.38M | Sell |
56,813
-1,636
| -3% | -$130K | 0.97% | 31 |
|
|
2015
Q3 | $4.81M | Sell |
58,449
-4,554
| -7% | -$405K | 1.14% | 29 |
|
|
2015
Q2 | $5.55M | Sell |
63,003
-4,503
| -7% | -$413K | 1.05% | 28 |
|
|
2015
Q1 | $5.96M | Sell |
67,506
-1,361
| -2% | -$121K | 1.13% | 24 |
|
|
2014
Q4 | $5.72M | Sell |
68,867
-1,507
| -2% | -$125K | 1.08% | 26 |
|
|
2014
Q3 | $5.94M | Sell |
70,374
-19,173
| -21% | -$1.55M | 1.14% | 25 |
|
|
2014
Q2 | $7.26M | Sell |
89,547
-1,674
| -2% | -$132K | 1.33% | 24 |
|
|
2014
Q1 | $6.95M | Sell |
91,221
-4,531
| -5% | -$330K | 1.29% | 24 |
|
|
2013
Q4 | $6.9M | Sell |
95,752
-3,180
| -3% | -$221K | 1.32% | 23 |
|
|
2013
Q3 | $6.8M | Sell |
98,932
-13,550
| -12% | -$896K | 1.38% | 24 |
|
|
2013
Q2 | $7.13M | Buy |
+112,482
| New | +$7.32M | 1.49% | 21 |
|
Other funds holding NVS
John G. Ullman & Associates's NVS Position: Q1 2026 in Review
John G. Ullman & Associates sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,530 shares — an estimated $211K sold.
John G. Ullman & Associates first reported a position in NVS in Q2 2013 and held it in 51 quarters. The position peaked at $18.9M in Q2 2024. 1,599 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- John G. Ullman & Associates reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
- John G. Ullman & Associates sold 1,530 Novartis shares in Q1 2026, an estimated $211K.
- John G. Ullman & Associates first reported a position in Novartis in Q2 2013 and held it in 51 quarters.
- John G. Ullman & Associates's Novartis position peaked at $18.9M in Q2 2024.
- 1,599 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on John G. Ullman & Associates's 13F filing for Q1 2026, filed 6 May 2026.